Woodline Partners LP Pharvaris N.V. Transaction History
Woodline Partners LP
- $13.5 Billion
- Q4 2024
A detailed history of Woodline Partners LP transactions in Pharvaris N.V. stock. As of the latest transaction made, Woodline Partners LP holds 44,514 shares of PHVS stock, worth $734,035. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,514Holding current value
$734,035% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PHVS
# of Institutions
53Shares Held
39.1MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$124 Million5.17% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.4MShares$72.5 Million77.49% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$70.7 Million67.66% of portfolio
-
Viking Global Investors LP3.65MShares$60.2 Million0.24% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$54.5 Million17.1% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $557M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...